Aadi Bioscience Inc
NASDAQ:AADI
Income Statement
Earnings Waterfall
Aadi Bioscience Inc
Income Statement
Aadi Bioscience Inc
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
20
+1 415%
|
20
+0%
|
20
0%
|
19
-7%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+115%
|
15
+3 388%
|
0
-97%
|
0
-19%
|
0
-66%
|
1
+833%
|
3
+206%
|
7
+97%
|
11
+63%
|
15
+38%
|
19
+23%
|
22
+15%
|
23
+8%
|
24
+5%
|
24
-2%
|
24
0%
|
25
+5%
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
5
+146%
|
9
+70%
|
14
+56%
|
17
+23%
|
20
+14%
|
21
+8%
|
22
+2%
|
21
-3%
|
21
-1%
|
22
+6%
|
|
| Operating Income | |||||||||||||||||||||||||||||||||
| Operating Expenses |
(17)
|
(17)
|
(18)
|
(18)
|
(21)
|
(24)
|
(26)
|
(29)
|
(31)
|
(33)
|
(30)
|
(28)
|
(23)
|
(20)
|
(18)
|
(16)
|
(21)
|
(17)
|
(17)
|
(27)
|
(38)
|
(122)
|
(64)
|
(69)
|
(73)
|
(83)
|
(86)
|
(91)
|
(93)
|
(96)
|
(91)
|
(85)
|
|
| Selling, General & Administrative |
(5)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(13)
|
(13)
|
(12)
|
(10)
|
(9)
|
(5)
|
(3)
|
(9)
|
(4)
|
(4)
|
(11)
|
(19)
|
(26)
|
(36)
|
(39)
|
(40)
|
(42)
|
(44)
|
(45)
|
(45)
|
(44)
|
(40)
|
(36)
|
|
| Research & Development |
(11)
|
(11)
|
(11)
|
(10)
|
(12)
|
(14)
|
(15)
|
(16)
|
(18)
|
(19)
|
(17)
|
(16)
|
(13)
|
(9)
|
(12)
|
(12)
|
(13)
|
(13)
|
(12)
|
(16)
|
(20)
|
(24)
|
(28)
|
(31)
|
(33)
|
(37)
|
(42)
|
(46)
|
(49)
|
(52)
|
(51)
|
(49)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(73)
|
0
|
0
|
0
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(17)
N/A
|
(17)
-3%
|
(18)
-7%
|
(18)
0%
|
(21)
-16%
|
(24)
-13%
|
(25)
-2%
|
(9)
+65%
|
(11)
-30%
|
(13)
-12%
|
(12)
+8%
|
(28)
-140%
|
(23)
+19%
|
(20)
+13%
|
(18)
+9%
|
(16)
+13%
|
(6)
+59%
|
(17)
-165%
|
(16)
+4%
|
(27)
-65%
|
(37)
-39%
|
(119)
-222%
|
(58)
+52%
|
(59)
-3%
|
(59)
+1%
|
(66)
-11%
|
(67)
-2%
|
(70)
-4%
|
(72)
-3%
|
(75)
-4%
|
(71)
+5%
|
(64)
+10%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
(0)
|
0
|
(1)
|
1
|
1
|
1
|
1
|
0
|
1
|
2
|
4
|
5
|
6
|
6
|
6
|
5
|
5
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(2)
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(74)
|
(74)
|
0
|
(78)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(17)
N/A
|
(18)
-5%
|
(19)
-6%
|
(19)
+1%
|
(21)
-14%
|
(24)
-11%
|
(24)
-2%
|
(8)
+67%
|
(10)
-28%
|
(11)
-10%
|
(11)
+3%
|
(27)
-145%
|
(23)
+15%
|
(19)
+20%
|
(18)
+5%
|
(16)
+10%
|
(4)
+73%
|
(17)
-288%
|
(15)
+13%
|
(99)
-576%
|
(110)
-11%
|
(120)
-9%
|
(135)
-13%
|
(63)
+54%
|
(61)
+3%
|
(62)
-2%
|
(62)
+0%
|
(63)
-3%
|
(66)
-4%
|
(69)
-5%
|
(65)
+5%
|
(62)
+6%
|
|
| Net Income | |||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(17)
|
(18)
|
(19)
|
(19)
|
(21)
|
(24)
|
(24)
|
(8)
|
(10)
|
(11)
|
(11)
|
(27)
|
(23)
|
(19)
|
(18)
|
(16)
|
(4)
|
(17)
|
(15)
|
(99)
|
(110)
|
(120)
|
(135)
|
(63)
|
(61)
|
(62)
|
(62)
|
(63)
|
(66)
|
(69)
|
(65)
|
(62)
|
|
| Net Income (Common) |
(21)
N/A
|
(22)
-3%
|
(22)
-2%
|
(21)
+6%
|
(22)
-8%
|
(24)
-7%
|
(24)
-2%
|
(8)
+67%
|
(10)
-28%
|
(11)
-10%
|
(11)
+3%
|
(27)
-145%
|
(23)
+15%
|
(19)
+20%
|
(18)
+5%
|
(16)
+10%
|
(4)
+73%
|
(17)
-288%
|
(15)
+13%
|
(99)
-576%
|
(110)
-11%
|
(120)
-9%
|
(135)
-13%
|
(63)
+54%
|
(61)
+3%
|
(62)
-2%
|
(62)
+0%
|
(63)
-3%
|
(66)
-4%
|
(69)
-5%
|
(65)
+5%
|
(62)
+6%
|
|
| EPS (Diluted) |
-11.61
N/A
|
-12.02
-4%
|
-12.2
-1%
|
-11.48
+6%
|
-12.41
-8%
|
-13.24
-7%
|
-13.35
-1%
|
-2.97
+78%
|
-4.6
-55%
|
-4.22
+8%
|
-4.11
+3%
|
-10.1
-146%
|
-8.6
+15%
|
-6.91
+20%
|
-7.34
-6%
|
-6.27
+15%
|
-1.52
+76%
|
-5.31
-249%
|
-1.29
+76%
|
-10.39
-705%
|
-12.34
-19%
|
-5.71
+54%
|
-6.44
-13%
|
-2.94
+54%
|
-2.69
+9%
|
-2.3
+14%
|
-2.29
+0%
|
-2.36
-3%
|
-2.44
-3%
|
-2.55
-5%
|
-2.42
+5%
|
-2.29
+5%
|
|